VIDAS D-Dimer Exclusion II 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Biomerieux 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-01-23
  • 사례 출판 날짜
    2013-01-23
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: biomérieux vidas d-dimer exclusion ii health canada has posted a medical device safety alert concerning vidas d-dimer exclusion ii manufactured by biomérieux. the affected model/catalogue and lot/serial numbers are 30455 and 1001399220 respectively. the manufacturer has registered two complaints on false negative results under the detection limit (<45 ng/ml) using the batch 1001399220. the investigation indicates that there is the potential for a manufacturing issue to be the cause of the problem and root cause investigations are in-process. the impact of a false negative d-dimer test result could be critical for the patient because it could prevent further diagnostic workup for venous thromboembolism and withhold anticoagulant treatment when it is actually needed, resulting in a negative impact to patient care. as a preventive measure, biomérieux has decided to remove the suspect product from the field. furthermore, all affected users are advised to take the following necessary actions: stop using and destroy the affected products. perform a retrospective analysis of the patients tested on this batch and investigate further (e.G. final diagnosis and clinical status of the patient) if the result is < 45 ng/ml. according to the local supplier, the affected products are distributed in hong kong. for details, please visit the following health canada website: http://www.Hc-sc.Gc.Ca/dhp-mps/compli-conform/recall-retrait/_list/ rec-ret_md-im_date_jan-mar_2013-eng.Php if you are in possession of the product, please contact your supplier for necessary actions. posted on 23 january 2013.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Biomerieux VIDAS D-Dimer Exclusion II
  • Manufacturer

Manufacturer